Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02242032 · ClinicalTrials.gov registry record · Phase 1
Study of the Safety and Tolerability of P 321 Ophthalmic Solution in Subjects With Dry Eye Disease
A Phase 1 study, sponsored by Parion Sciences.
- Completed
- Registry status
- Phase 1
- Development phase
- 53
- Enrollment target
NCT02242032 is a Phase 1 study that has completed, run by Parion Sciences. The registered enrollment target is 53 participants.
The verdict
NCT02242032, a Phase 1 study, has completed, sponsored by Parion Sciences.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 53 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the safety and tolerability of P-321 Ophthalmic Solution in subjects with mild to moderate dry eye disease.
Interventions
- DRUG P-321 Ophthalmic Solution
- DRUG P-321 Ophthalmic Solution placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2014-07 |
| Est. Completion | 2015-03 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02242032
The ClinicalTrials.gov registry entry for NCT02242032 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 53 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Parion Sciences, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which P-321 Ophthalmic Solution is the first listed.
NCT02242032 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02242032 about?
NCT02242032 is a clinical study titled "Study of the Safety and Tolerability of P 321 Ophthalmic Solution in Subjects With Dry Eye Disease". The purpose of this study is to assess the safety and tolerability of P-321 Ophthalmic Solution in subjects with mild to moderate dry eye disease.
What is the current status of trial NCT02242032?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 53 participants. The study started on 2014-07. Estimated completion is 2015-03.
What interventions are being tested in trial NCT02242032?
The interventions under investigation include: P-321 Ophthalmic Solution (DRUG), P-321 Ophthalmic Solution placebo (DRUG).
Who is sponsoring clinical trial NCT02242032?
This trial is sponsored by Parion Sciences, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.